A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers
Status:
Completed
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
The objectives of this study is to access the pharmacokinetics and safety of HMS5552 in
single dose in renal impaired subjects and matched healthy adult subjects.